Measuring the impact of monoclonal antibody therapies

ObjectiveMonoclonal antibody (Mab) treatments have significantly improved the quality and quantity of life, but they are some of the most expensive treatments, resulting in a degree of hesitancy to introduce new Mab agents. A system for estimating the effect of Mab drugs, in general, would optimally...

全面介绍

书目详细资料

Principais autores:	Ka Keat Lim, Kenrick Ng, Sathiyaa Balachandran, Mark D. Russell, Amy Boalch, Alasdair Sinclair, Bolaji Coker, Krishna Vinnakota, Rashid Mansoor, Abdel Douiri, Lara V. Marks, Steven Sacks
格式:	Artigo
语言:	Inglês
出版:	Frontiers Media S.A. 2023-11-01
丛编:	Frontiers in Medicine
主题:	monoclonal antibodies real world data (RWD) systematic literature review meta-analysis cost benefit evaluation
在线阅读:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1256712/full
标签:	添加标签 没有标签, 成为第一个标记此记录!